Lin Yu-Hsin
Lin Yu-Hsin, CEO, reported an open-market or private sale at BELITE BIO, INC involving 600.000000 shares for an estimated $114232.02. Reported holdings after the transaction were 119534.000000 shares. The stored filing text includes a detected 10b5-1 reference.
- Trade date
- Sep 04, 2026
- Filing date
- Sep 09, 2026
How reported position traded is calculated
Shares sold ÷ (holdings after + shares sold). Estimated position before: 120,134 shares.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
BLTE price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- Sell Code S
- Identifier
- 0001193125-26-386794 American depositary share
- Transaction date
- Sep 04, 2026 Filed Sep 09, 2026, 11:39 PM · 5d delay
- Shares
- 600 sh $190.39 per share
- Estimated value
- -$114k Computed from shares × price
- Holdings after
- 119,534 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
-4 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - tenb5_1_detected-10 points
is_10b5_1 = true
Stored filing content includes detected 10b5-1 language.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Chief Executive Officer
- F1
Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer.
- F2
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/23/2025.
- F3
Represents the weighted average price of shares sold at prices that ranged from $180 to $180.96. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a securi…
- F4
Represents the weighted average price of shares sold at prices that ranged from $181 to $181.93. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a securi…
- F5
Represents the weighted average price of shares sold at prices that ranged from $182 to $182.91. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a securi…
- F6
Represents the weighted average price of shares sold at prices that ranged from $183 to $183.72. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a securi…
- F7
Represents the weighted average price of shares sold at prices that ranged from $184 to $184.95. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a securi…
- F8
Represents the weighted average price of shares sold at prices that ranged from $185.01 to $185.975. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a se…
- F9
Represents the weighted average price of shares sold at prices that ranged from $186 to $186.98. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a securi…
- F10
Represents the weighted average price of shares sold at prices that ranged from $187 to $187.78. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a securi…
- F11
Represents the weighted average price of shares sold at prices that ranged from $188 to $188.9. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a securit…
- F12
Represents the weighted average price of shares sold at prices that ranged from $189 to $189.99. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a securi…
- F13
Represents the weighted average price of shares sold at prices that ranged from $190 to $190.58. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a securi…
- F14
Represents the weighted average price of shares sold at prices that ranged from $191 to $191.99. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a securi…
- F15
Represents the weighted average price of shares sold at prices that ranged from $192 to $192.85. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a securi…
- F16
Represents the weighted average price of shares sold at prices that ranged from $193 to $193.33. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a securi…
- F17
Represents the weighted average price of shares sold at prices that ranged from $194 to $194.98. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a securi…
- F18
Represents the weighted average price of shares sold at prices that ranged from $195 to $195.995. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a secur…
- F19
Represents the weighted average price of shares sold at prices that ranged from $196.01 to $196.99. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a sec…
- F20
Represents the weighted average price of shares sold at prices that ranged from $197 to $197.99. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a securi…
- F21
Represents the weighted average price of shares sold at prices that ranged from $198 to $198.37. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a securi…
0 other transactions
0 recent txs